⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockFranceNasdaqGS

SNY

Sanofi

Healthcare · Drug Manufacturers - General

42.85USD

-0.3050 (-0.71%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(EUR)
1)

Issue Data

Last PxUSD / 42.85
P/E26.1
Dvd Ind Yld5.5%
P/B1.49
P/S2.1
Curr EV/T12M EBITDA—
Mkt Cap (USD)103.4B
Curr EV (USD)—
2)

Per Share Data

EPS T12M1.63
DPS1.99
Bk Val Per Sh33.32
Rev/Sh20.44
Cash/Sh2.65
Curr Shares Out2,396.1M
FCF/Sh3.52
3)

Cash Flow Analysis

P/CF8.7
Curr P/FCF12.3
CF/NI3.0
Dvd P/O120.6%
Cash Gen/Cash Reqd1.4
Csh Dvd Cov2.5
CFO/Sales24.2%
Eff Interest Rate3.5%
4)

Growth Potential

Dil EPS 1Y Gr38.8%
Cap 1Y Gr-3.8%
BPS 1Y Gr-6.0%
R&D To Sales16.6%
Retention Rate-20.6%
Rev 1Y Gr5.5%
FCF 1Y Gr22.5%
Assets 1Y Gr-4.5%
5)

Profitability

EBITDA15.3B
EBIT10.1B
Operating Margin20.6%
Pretax Margin11.1%
Net Margin8.1%
ROA3.1%
ROE5.7%
ROC8.6%
Asset Turnover0.39
6)

Structure

Current Ratio0.99
Quick Ratio0.49
Debt/Assets16.8%
Debt/Com Eq31.3%
Net Debt/EBITDA1.00
Tot Debt/Capital23.8%
Gross Margin72.8%
EBIT/Int Exp13.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years. This company reports in a different currency from the one its shares trade in, so any ratio dividing a market value by a statement figure crosses that boundary un-converted.